What is evidence?
- PMID: 20683888
- PMCID: PMC2917254
- DOI: 10.1002/sim.3933
What is evidence?
Abstract
The assumption that comparative effectiveness research will provide timely, relevant evidence rests on changing the current framework for assembling evidence. In this commentary, we provide the background of how coverage decisions for new medical technologies are currently made in the United States. We focus on the statistical issues regarding how to use the ensemble of information for inferring comparative effectiveness. It is clear a paradigm shift in how clinical information is integrated in real-world settings to establish effectiveness is required.
Copyright (c) 2010 John Wiley & Sons, Ltd.
Comment on
-
Comparative effectiveness research: Policy context, methods development and research infrastructure.Stat Med. 2010 Aug 30;29(19):1963-76. doi: 10.1002/sim.3818. Stat Med. 2010. PMID: 20564311
Similar articles
-
Vascular specialist response to medicare evidence development coverage advisory committee (MEDCAC) panel on peripheral artery disease of the lower extremities.Catheter Cardiovasc Interv. 2016 Jun;87(7):1181-6. doi: 10.1002/ccd.26512. Epub 2016 Apr 10. Catheter Cardiovasc Interv. 2016. PMID: 27062192 No abstract available.
-
Enhancing the quality of care in the intensive care unit: a systems engineering approach.Crit Care Clin. 2013 Jan;29(1):113-24. doi: 10.1016/j.ccc.2012.10.009. Crit Care Clin. 2013. PMID: 23182531 Review.
-
Medicare is scrutinizing evidence more tightly for national coverage determinations.Health Aff (Millwood). 2015 Feb;34(2):253-60. doi: 10.1377/hlthaff.2014.1123. Health Aff (Millwood). 2015. PMID: 25646105
-
On the limitations of comparative effectiveness research.Stat Med. 2010 Aug 30;29(19):1991-5; discussion 1996-7. doi: 10.1002/sim.3960. Stat Med. 2010. PMID: 20683890 No abstract available.
-
Evaluation of technologies approved for supplemental payments in the United States.BMJ. 2019 Jun 17;365:l2190. doi: 10.1136/bmj.l2190. BMJ. 2019. PMID: 31209124 Free PMC article. Review.
Cited by
-
Effect of Treatment in a Specialized Pediatric Hemato-Oncology Setting on 5-Year Survival in Acute Lymphoblastic Leukemia: A Quasi-Experimental Study.Cancers (Basel). 2022 May 16;14(10):2451. doi: 10.3390/cancers14102451. Cancers (Basel). 2022. PMID: 35626054 Free PMC article.
-
Radioembolization results in longer time-to-progression and reduced toxicity compared with chemoembolization in patients with hepatocellular carcinoma.Gastroenterology. 2011 Feb;140(2):497-507.e2. doi: 10.1053/j.gastro.2010.10.049. Epub 2010 Oct 30. Gastroenterology. 2011. PMID: 21044630 Free PMC article.
-
Building the evidence base for decision making in cancer genomic medicine using comparative effectiveness research.Genet Med. 2012 Jul;14(7):633-42. doi: 10.1038/gim.2012.16. Genet Med. 2012. PMID: 22516979 Free PMC article. Review.
-
Adjusting for confounding by indication in observational studies: a case study in traumatic brain injury.Clin Epidemiol. 2018 Jul 18;10:841-852. doi: 10.2147/CLEP.S154500. eCollection 2018. Clin Epidemiol. 2018. PMID: 30050328 Free PMC article.
-
Multiple outcomes and multiple sources of evidence: best statistical practices.Circ Cardiovasc Qual Outcomes. 2011 Nov 1;4(6):579-80. doi: 10.1161/CIRCOUTCOMES.111.963751. Circ Cardiovasc Qual Outcomes. 2011. PMID: 22085981 Free PMC article. No abstract available.
References
-
- [January 8, 2010]. See http://www.cms.hhs.gov/FACA/02_MEDCAC.asp.
-
- [January 8, 2010]. See http://www.cms.hhs.gov/FACA/Downloads.recommendations.pdf.
-
- Greenlander S, O’Rourke K. On the bias produced by quality scores in meta-analysis, and a hierarchical view of proposed solutions. Biostatistics. 2001;2(4):463–471. - PubMed
-
- Juni P, Witschi A, Block R, Egger M. The hazards of scoring the quality of clinical trials for meta-analysis. Journal of the American Medical Association. 1999;282:1054–1060. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources